Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?

Current diabetes reviews - 1 Feb 2007

Lely A Titia, Luik Peter T, Navis Gerjan

Abstract excerpt

The renin-angiotensin aldosterone system (RAAS) is well-established to be involved in diabetic nephropathy. Several abnormalities in the RAAS have been described in diabetes mellitus, including an abnormal aldosterone to renin ratio, elevated angiotensin I-converting enzyme (ACE) levels, and altered angiotensin II sensitivity. Whereas the renoprotective properties of ACE-inhibition in diabetic nephropathy have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Diabetic Nephropathies
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ACE gene

Share to Genotype

Share to Models, Biological

Share to Peptidyl-Dipeptidase A

Share to Renin-Angiotensin System

Source

Identifiers

PMID: 18220655
DOI: 10.2174/157339907779802049

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?PMID 18220655Read ↗

Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review.Semantic proximity Read ↗

Angiotensin-converting enzyme gene and diabetes mellitus.Semantic proximity Read ↗

ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.Semantic proximity Read ↗

Diabetic nephropathy and genetic alterations of the renin-angiotensin-system.Semantic proximity Read ↗

The pathogenesis of diabetic nephropathy.Semantic proximity Read ↗

ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.Semantic proximity Read ↗

Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.Semantic proximity Read ↗

Predicting the development of diabetic nephropathy and its progression.Semantic proximity Read ↗

Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease.Semantic proximity Read ↗

Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms.Semantic proximity Read ↗

Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene.Semantic proximity Read ↗

Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.